CN206675582U - A kind of absorbable uterine cavity sacculus - Google Patents
A kind of absorbable uterine cavity sacculus Download PDFInfo
- Publication number
- CN206675582U CN206675582U CN201621375715.6U CN201621375715U CN206675582U CN 206675582 U CN206675582 U CN 206675582U CN 201621375715 U CN201621375715 U CN 201621375715U CN 206675582 U CN206675582 U CN 206675582U
- Authority
- CN
- China
- Prior art keywords
- sacculus
- return valve
- uterine cavity
- sleeve pipe
- absorbable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Surgical Instruments (AREA)
Abstract
The utility model discloses a kind of absorbable uterine cavity sacculus, including the sacculus to match with uterine cavity shape；Non-return valve, the opening sleeve of sacculus is on the outlet outer wall of non-return valve, and during original state, sacculus is placed in the passage of non-return valve in the state folded；Sleeve pipe, its end and non-return valve are detachably discretely connected installation；The sacculus and non-return valve are made by harmless and absorbable biodegradation material.Because sleeve pipe and non-return valve can be separated from each other between the two, after sacculus is charged liquid or gas and becomes full, sleeve pipe and non-return valve separation can be achieved, it is non-return valve and sacculus to be retained in uterine cavity.Sleeve pipe completely retains and can be kept completely separate out uterine cavity, and any bad influence will not be caused to patient.
Description
Technical field
The utility model is related to biomaterial and medicine equipment, and in particular to it is a kind of for hemostasis in uterine cavity, prevent adhesion
Absorbable uterine cavity sacculus.
Background technology
Asherman's syndrom is common and occurred frequently intrauterine disease, caused by it has more than 90% to be all dilatation and curettage, using scraping
The important sources of the modus operandi in palace are to hang palace in artificial abortion operation and postpartum.What according in January, 2015, China Youth News counted
Data, the annual artificial abortion operation of China are up to 13,000,000 person-times.In addition hysteroscope operation, the damage of uterus inwall is caused,
Also adhesion is easily triggered.
The harm of Asherman's syndrom has：Hypomenorrhia, amenorrhoea, periodic abdominalgia, female acyesis：Secondary infertility flows repeatedly
Production, premature labor.Because Asherman's syndrom endometrium is destroyed, uterine volume reduces, and can also influence the normal implantation of embryo and cause not
It is pregnant, even if becoming pregnant the embryo after also contributing to bed, embryo growth and development, so that miscarriage and premature labor.
The therapeutic modality of Asherman's syndrom is at present：Asherman's syndrom exclusion under hysteroscope.Such Post operation, Asherman's syndrom are multiple
Hair rate is up to 62.5%.To prevent postoperative Asherman's syndrom generation and recurrence rate, clinically often given birth to using liquid gel, solid-state
The anti-sticking by-product such as thing film.Liquid gel often because mobility, degraded it is too fast the reason for so that preventing adhesiving effect is poor；Solid film
Product is because using operation inconvenience, adhesion is poor, the problems such as covering dead angle be present nor a kind of preferable solution.Therefore face
Need a kind of easy to use on bed, uterine cavity safe and reliable, that curative effect is excellent prevents adhesion solution and device product.
At present, clinically there are various medicine equipments to prevent Asherman's syndrom, such as patent document CN103637836A
Disclosed " uterine cavity bonds even preventing and treating device ", the preventing and treating device can effectively prevent Asherman's syndrom in short-term and long-term, but this is anti-
The sacculus and sacculus guide pin bushing for controlling device are connected together, and sacculus is located in uterine cavity, and foley's tube connection sacculus is in introitus
Or it is external, be so chronically implanted, extraneous bacterium will gradually grow along foley's tube, into vagina and uterine cavity, formed vagina,
Uterine cavity inflammation, or even trigger the situation of severe infections.In addition, working as needs to Deflation, then need to cut at 1cm under uterine cavity collar extension
Intercept ductus bursae, and " 1cm ", the position are located at intravaginal under uterine cavity collar extension, and institute need to be entered by patient and is operated by medical personnel, such as
This, can not only increase the difficulty and complexity of operation, and have a strong impact on the comfort of user, cause patients ' psychological to bear.
Simultaneously as the sacculus and foley's tube of the program all have silastic material to be made, and its sacculus and sacculus are led
Pipe is still in uterine cavity and intravaginal, because silastic material is the material that human body can not decompose absorption, is treating
Cheng Hou, it need to be operated by second operation and take out sacculus and foley's tube.So operation, the complexity of Asherman's syndrom curing can be increased
Property, multiple operation technique can also increase healing risk and the financial burden of patient, or even sacculus is extracted from uterine cavity by force, hold
The secondary injury of uterine cavity inwall is easily caused, reduces success rate of operation.
Another patent document CN2645618Y discloses " trachea for separating conglutination of uterine cavity ", the conduit by spherical single capsule, single-chamber,
The foley's tube that unidirectional non-return introduction valve is formed, but be all by medical because its spherical single capsule and foley's tube are all integral
What high polymer material was made, therefore, there is also many disadvantages of above-mentioned " uterine cavity bonds even preventing and treating device " for it.And patent document
There is also above-mentioned " uterine cavity bonds even preventing and treating device " for " a kind of uterine cavity expansion tri-Lobe balloon catheter " disclosed in CN103750884A
Various defects.
As the above analysis, the medicine equipment for being currently used for preventing and treating uterine cavity bonding all lacks in the presence of following two kinds
Fall into：First, sacculus and sacculus guide pin bushing are formed integral, in use, sacculus is located in uterine cavity, foley's tube connection sacculus is in the moon
Road position is external.Once being chronically implanted, extraneous bacterium will gradually grow along foley's tube, into vagina and uterine cavity, shape
Into vagina, uterine cavity inflammation, or even the situation that severe infections will be triggered.2nd, sacculus and sacculus guide pin bushing can not be absorbed using human body
What elastomeric material was made, because sacculus is located in uterine cavity, it is necessary to the taking-up operation of sacculus be carried out, if sacculus is sent out with uterine cavity
When raw adhesion is not easy to be separated, once careless manipulation, easily causes the secondary damage of uterine cavity inwall, forms uterine cavity inwall wound
Wound, then causes adhesion to occur again.
Utility model content
In view of the shortcomings of the prior art, the utility model aims to provide a kind of absorbable uterine cavity sacculus
To achieve the above object, the utility model adopts the following technical scheme that：
A kind of absorbable uterine cavity sacculus, including
Sacculus, it matches with uterine cavity shape；
Non-return valve, the opening sleeve of sacculus is on the outlet outer wall of non-return valve；On the outlet outer wall of the non-return valve also
It is provided with external screw thread；
Sleeve pipe, its end and non-return valve are detachably discretely connected installation；
The sacculus and non-return valve are made by harmless and absorbable biodegradation material.
Helical structure is provided with the passage of described sleeve pipe end, spiral buckle is provided with the outer wall of non-return valve；When
When sleeve pipe and non-return valve spin, spiral buckle fastens with helical structure, and sleeve pipe and non-return valve form one；When revoling tube,
Spiral buckle departs from helical structure, and sleeve pipe and non-return valve realize separation.
Described harmless and absorbable biodegradation material is that polylactide, PGA, poly (glycolide-lactide) are common
It is polymers, polyamide, polyester, polyesteramide, polyanhydride, poe, polyphosphazene, false polyaminoacid, polyglycereol-sebacate, poly-
Caprolactone, polycaprolactone derivatives, the polyesteramide based on amino alcohol, poly- octane glycol citrate, one kind in hydrogel,
A variety of or copolymer, and degradable magnesium alloy.
Holding rotating part is provided with the bottom outer wall of described sleeve pipe.
The wall thickness of the sacculus is 0.05~0.1mm.
Above-mentioned absorbable uterine cavity sacculus also includes the push rod being set in sleeve channel, and card is provided with the top of push rod
Button；The neck that installation is engaged with buckle is offered in the top face of the non-return valve.
Fine needle is additionally provided with the buckle, when buckle and neck cooperation installation, fine needle inserts the passage of non-return valve
In.
Base is set on the top outer wall of the push rod.
Described sleeve pipe is formed by plastic production, and the internal diameter of sleeve pipe is 4~15mm, and external diameter is 7~18mm, and a length of 20cm~
40cm。
The beneficial effects of the utility model are：
Absorbable uterine cavity sacculus of the present utility model has as follows compared with the medicine equipment that existing prevention uterine cavity bonds
Difference：
A. after sacculus, which is charged liquid or gas, becomes full, sleeve pipe and non-return valve separation can be achieved, be retained in palace
Intracavitary is non-return valve and sacculus.Sleeve pipe completely retains and can be kept completely separate out uterine cavity, and any bad shadow will not be caused to patient
Ring.
B. due to the presence of non-return valve, sacculus can be caused to keep full state within a period of time, can effectively prevented
Only adherence recurrence.
C. because sacculus and non-return valve are by being made of safe to the human body and absorbable biodegradation material, so even
After sleeve pipe and non-return valve separation, sacculus and non-return valve can be voluntarily degraded after completing to treat without taking out, and catabolite is in palace
Naturally drained in vitro by vagina in chamber wound, the influence to patient can be reduced to greatest extent.
Brief description of the drawings
Fig. 1 is the assembly structure diagram that the utility model can absorb uterine cavity sacculus；
Fig. 2 is the structural representation of non-return valve；
Fig. 3 is the structural representation of sleeve pipe；
Fig. 4 is the structural representation of push rod；
Fig. 5 is that the absorbable uterine cavity sacculus of the utility model uses operational flowchart；
In figure：1st, sacculus；2nd, non-return valve；3rd, sleeve pipe；4th, push rod；21st, screw-button；22nd, neck；23rd, external screw thread；31st, spiral shell
Revolve structure；32nd, rotating part is held；41st, buckle；42nd, fine needle；43rd, base.
Embodiment
With reference to accompanying drawing and embodiment, the utility model is described in detail below：
As shown in figure 1, absorbable uterine cavity sacculus of the present utility model, including the sacculus 1 to match with uterine cavity shape, specifically
, when the sacculus 1 deploys, in the triangle of a band " goat's horn ", to match uterine cavity shape；Non-return valve 2, the opening sleeve of sacculus 1
On the outlet outer wall of non-return valve 2, during original state, sacculus 1 is placed in the passage of non-return valve 2 in the state folded, also
It is to say, in original state, sacculus 1 and non-return valve 2 form integral, and non-return valve 2 can only be one-way air inlet, in this way,
Sacculus 1 is discharged after uterine cavity, and sacculus 1 can be caused to keep full state within a period of time；Sleeve pipe 3, its end and check
The detachable installation that is discretely connected of valve 2, that is to say, that sleeve pipe 3 and non-return valve 2 can be separated from each other between the two；And
Above-mentioned sacculus 1 and non-return valve 2 is made by harmless and absorbable biodegradation material, that is to say, that i.e.
Just sacculus 1 and non-return valve 2 are retained in uterine cavity, and sacculus 1 and non-return valve 2 can also be absorbed by the body.
Therefore, as the above analysis, absorbable uterine cavity sacculus of the present utility model glues with existing prevention and treatment uterine cavity
The medicine equipment of knot is compared, and has following difference：First, because sleeve pipe 3 and non-return valve 2 are to be separated from each other between the two
, in this way, after sacculus 1 is charged liquid or gas and becomes full, sleeve pipe 3 and non-return valve 2 can be separated, that is,
Say, be finally retained in intrauterine only non-return valve 2 and sacculus 1, sleeve pipe 3 can easily be kept completely separate out uterine cavity without cutting
Interior, therefore, sleeve pipe 3 will not cause any bad influence to patient.2nd, due to sacculus 1 and non-return valve 2 by be to human body without
What harmful and absorbable biodegradation material was made, even if in this way, after sleeve pipe 3 and non-return valve 2 separate, sacculus 1 and check
Valve 2 permanent will not be also retained in uterine cavity, it is therefore not necessary to sacculus 1 and non-return valve 2 are taken out, can be reduced to greatest extent pair
The influence of patient, simultaneously as the presence of non-return valve 2, can cause sacculus to keep full state within a period of time, can have
Prevent adherence recurrence to effect.
As Figure 2-3, helical structure 31 is provided with the passage of the above-mentioned end of sleeve pipe 3, is set on the outer wall of non-return valve 2
It is equipped with screw-button 21；When sleeve pipe 3 and non-return valve 2 spin, screw-button 21 is snapped in helical structure 31, sleeve pipe 3 and non-return valve 2
Form one；When revoling tube 3, screw-button 21 departs from helical structure 31, and sleeve pipe 3 and non-return valve 2 realize separation.Certain sleeve pipe
3 and non-return valve 2 mounting means can also use other modes between the two, such as by the way of screw thread spins etc., if its
It can realize that both sleeve pipe and non-return valve detachably separate in uterine cavity.
In addition, securely it is set on the outlet outer wall of non-return valve 2 for the ease of sacculus 1, on the outlet outer wall of non-return valve 2
External screw thread 23 is additionally provided with, in this way, under external screw thread 23 and sacculus 1 elastic reaction of itself, sacculus 1 can be securely bonded
In on the outlet outer wall of non-return valve 2.
Wherein, above-mentioned harmless and absorbable biodegradation material is polylactide, PGA, poly- second third are handed over
Ester copolymer, polyamide, polyester, polyesteramide, polyanhydride, poe, polyphosphazene, false polyaminoacid, polyglycereol-decanedioic acid
In ester, polycaprolactone, polycaprolactone derivatives, the polyesteramide based on amino alcohol, poly- octane glycol citrate, hydrogel
A kind of, a variety of or copolymer, and degradable magnesium alloy.And specific in the present embodiment, above-mentioned human body is harmless and absorbable
Biodegradation material be PLA.
It is provided with the bottom outer wall of above-mentioned sleeve pipe 3 and holds rotating part 32, in order to revoling tube 3.
For sacculus 1 and non-return valve 2 successfully are sent into uterine cavity, it is necessary to the design size of non-return valve 2 is smaller, so if
If the wall thickness of sacculus 1 is blocked up, then it is difficult to realize and is placed in sacculus 1 in the passage of non-return valve 2, if however, the wall thickness of sacculus 1
If excessively thin, sacculus 1 is more fragile, easily damaged, and therefore, utility model people has found by substantial amounts of research, when the wall of above-mentioned sacculus 1
When thickness is 0.05~0.1mm, not only being folded and placed in the passage of non-return valve 2 in order to sacculus 1, and ball can be ensured
The service life of capsule 1, and the wall thickness of sacculus 1 is 0.08mm in the present embodiment.
In addition, direct revoling tube 3, although sleeve pipe 3 and non-return valve 2 can be realized into separation between the two, simultaneously
There can be the problem of following：Before sleeve pipe 3 and non-return valve 2 do not separate, direct revoling tube 3, the check being screwed on sleeve pipe 3
Valve 2 and sacculus 1 also, in this way, sacculus 1 can cause to collide during rotation to uterine cavity inwall, can just have along with rotation
Uterine cavity inwall may be caused to damage.In order to solve the above problems, as shown in figure 1, absorbable uterine cavity ball of the present utility model
Capsule also includes the push rod 4 being set in the passage of sleeve pipe 3, as shown in figure 4, the push rod 4 is tubule structures, in the top of push rod 4
Buckle 41 is provided with, correspondingly, as shown in figure 3, offering the neck that installation is engaged with buckle 41 in the top face of non-return valve 2
22, that is to say, that in practical operation in use, by by the plug-in-sleeve 3 of push rod 4 so that buckle 41 and the phase interworking of neck 22
Installation is closed, in this way, while revoling tube 3, does not allow it to follow sleeve pipe 3 to rotate as long as push rod 4 is fixed, then non-return valve 2
Also sleeve pipe 3 will not be followed by rotate, so as to efficiently solve because non-return valve 2 rotates and caused by uterine cavity damage the problem of.
As shown in figure 5, during absorbable uterine cavity sacculus actual use of the present utility model, following step is specifically wrapped
Suddenly：1. sleeve pipe 3 and non-return valve 2 (i.e. sacculus) connection are placed into uterine cavity；2. connection push rod 4 and absorption have quantitative physiological saline
Syringe；3. push rod 4 is pushed into sleeve pipe 3 so that the neck 22 of buckle 41 and the top face of non-return valve 2 on push rod 4 is engaged
Installation；4. to the injecting normal saline of sacculus 1 so that sacculus 1 is full；5. push rod 4 is held while revoling tube 3 so that sleeve pipe 3
Separated with non-return valve 2, finally take out sleeve pipe 3 and push rod 4.
Due to, needing that physiological saline note or gas are incident upon in sacculus 1 by syringe in actual use,
And in order to which sacculus 1 and non-return valve 2 successfully are sent into uterine cavity, it is necessary to the very little that non-return valve 2 is designed, so non-return valve 2 enters
Mouth passage can be very small, therefore is additionally provided with fine needle 42 in above-mentioned buckle 41, when buckle 41 and the cooperation installation of neck 22,
Fine needle 41 is inserted in the intake channel of non-return valve 2, in this way, smoothly efficiently can be pushed into liquid or gas by syringe
Sacculus 1, it is allowed to full expansion.
Wherein, above-mentioned buckle 41 and neck 22 are in a cross-shaped mode, in order to manufacture and buckle installation.
Base 43 is set on the top outer wall of above-mentioned push rod 4, by base 43, easily can be held on push rod 4, is prevented
Throw-out lever 4 followed by sleeve pipe 3 and rotate.
Above-mentioned sleeve pipe 3 is formed by plastic production, and the internal diameter of sleeve pipe 3 is 4~15mm, in order to which push rod 4 loads sleeve pipe 3
Interior, external diameter is 7~18mm, in order to enter vagina and pass through opening of the cervix；Meanwhile if long design, sleeve pipe 3 and push rod 4
Possible support force is inadequate, whereas if too short design, will cause sleeve pipe 4 and push rod 3 to be difficult to sacculus 1 being transported to uterine cavity
It is interior, therefore utility model people has found that, as a length of 20~40cm of sleeve pipe 3, sleeve pipe 3 and push rod 4 are not after substantial amounts of research
But there is preferable support force, and can cause sleeve pipe 3 and push rod 4 that sacculus is transported in uterine cavity.And specific to this implementation
In example, the internal diameter of sleeve pipe 3 is 8mm, external diameter 10mm, length 30cm.
It will be apparent to those skilled in the art that technical scheme that can be as described above and design, make other various
Corresponding change and deformation, and all these changes and deformation should all belong to the protection of the utility model claims
Within the scope of.
Claims (8)
- A kind of 1. absorbable uterine cavity sacculus, it is characterised in that includingSacculus, it matches with uterine cavity shape；Non-return valve, the opening sleeve of sacculus is on the outlet outer wall of non-return valve；It is additionally provided with the outlet outer wall of the non-return valve External screw thread；Sleeve pipe, its end and non-return valve are detachably discretely connected installation；The sacculus and non-return valve are made by harmless and absorbable biodegradation material.
- 2. absorbable uterine cavity sacculus as claimed in claim 1, it is characterised in that be provided with the passage of described sleeve pipe end Helical structure, spiral buckle is provided with the outer wall of non-return valve；When sleeve pipe and non-return valve spin, spiral buckle and helical structure Fasten, sleeve pipe and non-return valve form one；When revoling tube, spiral buckle departs from helical structure, and sleeve pipe and non-return valve are realized Separation.
- 3. absorbable uterine cavity sacculus as claimed in claim 1, it is characterised in that be provided with the bottom outer wall of described sleeve pipe Hold rotating part.
- 4. absorbable uterine cavity sacculus as claimed in claim 1, it is characterised in that the wall thickness of the sacculus is 0.05~0.1mm.
- 5. the absorbable uterine cavity sacculus as described in Claims 1 to 4 is any, it is characterised in that also include being set in sleeve channel Interior push rod, buckle is provided with the top of push rod；Offered in the top face of the non-return valve and installation is engaged with buckle Neck.
- 6. absorbable uterine cavity sacculus as claimed in claim 5, it is characterised in that fine needle is additionally provided with the buckle, when When buckle and neck coordinate installation, in the passage of fine needle insertion non-return valve.
- 7. absorbable uterine cavity sacculus as claimed in claim 5, it is characterised in that bottom is set on the top outer wall of the push rod Seat.
- 8. absorbable uterine cavity sacculus as claimed in claim 5, it is characterised in that described sleeve pipe is formed by plastic production, sleeve pipe Internal diameter be 4~15mm, external diameter is 7~18mm, a length of 20cm~40cm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201621375715.6U CN206675582U (en) | 2016-12-15 | 2016-12-15 | A kind of absorbable uterine cavity sacculus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201621375715.6U CN206675582U (en) | 2016-12-15 | 2016-12-15 | A kind of absorbable uterine cavity sacculus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN206675582U true CN206675582U (en) | 2017-11-28 |
Family
ID=60393798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201621375715.6U Active CN206675582U (en) | 2016-12-15 | 2016-12-15 | A kind of absorbable uterine cavity sacculus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN206675582U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106580386A (en) * | 2016-12-15 | 2017-04-26 | 成都迪康中科生物医学材料有限公司 | Absorbable uterine cavity saccule |
-
2016
- 2016-12-15 CN CN201621375715.6U patent/CN206675582U/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106580386A (en) * | 2016-12-15 | 2017-04-26 | 成都迪康中科生物医学材料有限公司 | Absorbable uterine cavity saccule |
| CN106580386B (en) * | 2016-12-15 | 2019-11-05 | 成都迪康中科生物医学材料有限公司 | A kind of absorbable uterine cavity sacculus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9555168B2 (en) | System for delivery of medication in treatment of disorders of the pelvis | |
| KR101592615B1 (en) | An intrauterine system | |
| US10814031B2 (en) | Systems and methods for incontinence control | |
| US4034749A (en) | Intrauterine contraceptive device | |
| CN201879873U (en) | Recyclable esophageal stent of nickel titanium memory alloy full-membrane exceeding opening | |
| CN102120059A (en) | Medicinal stent-graft for preventing and treating intrauterine adhesion | |
| CN103417272B (en) | Medicine distribution type uterus support | |
| WO2014106315A1 (en) | Intrauterine implant | |
| NO139429B (en) | INTRAUTERIN PREPARATION DEVICE FOR PEOPLE | |
| US5562654A (en) | Time-released delivery system | |
| CN103405845B (en) | A kind of Ileum fistulization tube | |
| CN106580386B (en) | A kind of absorbable uterine cavity sacculus | |
| CN109513097A (en) | A kind of two-tube balloon-stent for preventing and treating Asherman's syndrom | |
| CN206675582U (en) | A kind of absorbable uterine cavity sacculus | |
| Yan et al. | Recent progress in advanced biomaterials for long-acting reversible contraception | |
| CN203074772U (en) | Absorbable anti-adhesion diaphragm in uterine cavity of uterus | |
| CN208974938U (en) | A kind of de- biliary stent of the anti-work of sacculus | |
| CN110974504A (en) | Covered stent, preparation method thereof and weight-reducing stent system comprising covered stent | |
| CN104523362A (en) | Recoverable umbrella-shaped fallopian tube intrauterine device | |
| CN2647347Y (en) | Carrier suppository for gynecology | |
| CN1965912B (en) | Application of Chinese medicine polygala root as in-vitro spermaticide and method for preparing the medicament thereof | |
| CN201279218Y (en) | Chitose uterus-neck antibiotic film | |
| CN201618300U (en) | Novel vaginal sponge | |
| CN106821585A (en) | Novel contraceptive medical instrument | |
| CN102921098A (en) | Application of water absorbing material to medical tract dilator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |